Načítá se...
Membranous Nephropathy: Pilot Study of a Novel Regimen Combining Cyclosporine and Rituximab
INTRODUCTION: There is broad consensus that high-grade basal proteinuria and failure to achieve remission of proteinuria are key determinants of adverse renal prognosis in patients with primary membranous nephropathy. Since current regimens are not ideal due to short- and long-term toxicity and prop...
Uloženo v:
| Vydáno v: | Kidney Int Rep |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138549/ https://ncbi.nlm.nih.gov/pubmed/27942609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2016.05.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|